496 related articles for article (PubMed ID: 376552)
41. Post-receptor insulin resistance after diazoxide in non-insulin dependent diabetes.
Olczak SA; Greenwood RH; Hales CN
Horm Metab Res; 1986 Jan; 18(1):38-41. PubMed ID: 3949281
[TBL] [Abstract][Full Text] [Related]
42. Direct evidence for downregulation of insulin receptors by physiologic hyperinsulinemia in man.
Soman VR; DeFronzo RA
Diabetes; 1980 Feb; 29(2):159-63. PubMed ID: 6986303
[TBL] [Abstract][Full Text] [Related]
43. Effect of training and detraining on in vivo insulin sensitivity.
Nagasawa J; Sato Y; Ishiko T
Int J Sports Med; 1990 Apr; 11(2):107-10. PubMed ID: 2187003
[TBL] [Abstract][Full Text] [Related]
44. Effect of diabetes mellitus and insulin on the turnover and metabolic response to ketones in man.
Sherwin RS; Hendler RG; Felig P
Diabetes; 1976 Sep; 25(9):776-84. PubMed ID: 955305
[TBL] [Abstract][Full Text] [Related]
45. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
[TBL] [Abstract][Full Text] [Related]
46. Increase of insulin concentration in maturity-onset diabetics by phentolamine (Regitine) infusion.
Linde J; Deckert T
Horm Metab Res; 1973 Nov; 5(6):391-5. PubMed ID: 4766993
[No Abstract] [Full Text] [Related]
47. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D
J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
[TBL] [Abstract][Full Text] [Related]
48. Intravenous glucose infusion fails to alter monocyte insulin-binding affinity in normal subjects.
Kingston WJ; Livingston JN; Moxley RT
Horm Metab Res; 1985 Sep; 17(9):464-6. PubMed ID: 4043927
[TBL] [Abstract][Full Text] [Related]
49. Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.
Lerner RL; Porte D
J Clin Invest; 1972 Jul; 51(7):1624-31. PubMed ID: 4555783
[TBL] [Abstract][Full Text] [Related]
50. Comparison of insulin receptor binding to monocytes and erythrocytes in newly diagnosed type II diabetes mellitus.
Prager R; Schernthaner G
Horm Metab Res; 1982 Nov; 14(11):561-3. PubMed ID: 6759349
[TBL] [Abstract][Full Text] [Related]
51. Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus.
Pedersen O; Beck-Nielsen H; Heding L
N Engl J Med; 1980 Apr; 302(16):886-92. PubMed ID: 6987518
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.
Cavallo-Perin P; Cassader M; Bozzo C; Bruno A; Nuccio P; Dall'Omo AM; Marucci M; Pagano G
J Clin Invest; 1985 May; 75(5):1659-65. PubMed ID: 3889056
[TBL] [Abstract][Full Text] [Related]
53. Plasma acetate levels in response to intravenous fat or glucose/insulin infusions in diabetic and non-diabetic subjects.
Akanji AO; Ng L; Humphreys S
Clin Chim Acta; 1988 Nov; 178(1):85-94. PubMed ID: 3067912
[TBL] [Abstract][Full Text] [Related]
54. Effect of metabolic control on urinary excretion and plasma levels of catecholamines in diabetics.
Bolli G; Cartechini MG; Compagnucci P; Malvicini S; De Feo P; Santeusanio F; Angeletti G; Brunetti P
Horm Metab Res; 1979 Oct; 11(9):493-7. PubMed ID: 499999
[TBL] [Abstract][Full Text] [Related]
55. Blood glucose profiles in insulin-dependent Zambian diabetics.
Mulaisho C
Med J Zambia; 1979; 13(5):85-9. PubMed ID: 122431
[TBL] [Abstract][Full Text] [Related]
56. Diminished effect of caloric restriction on control of hyperglycemia with increasing known duration of type II diabetes mellitus.
Nagulesparan M; Savage PJ; Bennion LJ; Unger RH; Bennett PH
J Clin Endocrinol Metab; 1981 Sep; 53(3):560-8. PubMed ID: 7021580
[TBL] [Abstract][Full Text] [Related]
57. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.
Rizza RA; Mandarino LJ; Gerich JE
J Clin Endocrinol Metab; 1982 Jan; 54(1):131-8. PubMed ID: 7033265
[TBL] [Abstract][Full Text] [Related]
58. Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus.
Kimmerling G; Javorski C; Olefsky JM; Reaven GM
Diabetes; 1976 Aug; 25(8):673-8. PubMed ID: 955298
[TBL] [Abstract][Full Text] [Related]
59. Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog.
Bevilacqua S; Barrett EJ; Smith D; Simonson DC; Olsson M; Bratusch-Marrain P; Ferrannini E; DeFronzo RA
Metabolism; 1985 Sep; 34(9):817-25. PubMed ID: 3897768
[TBL] [Abstract][Full Text] [Related]
60. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.
DeFronzo RA; Simonson D; Ferrannini E
Diabetologia; 1982 Oct; 23(4):313-9. PubMed ID: 6754515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
